Modified oligonucleotides for telomerase inhibition
CA 2536015 C · Owner: Pongracz, Krisztina · Inventors: Gryaznov, Sergei; Pongracz, Krisztina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds comprising an oligonucleotide moiety covalently linked to a lipid moiety are disclosed. The oligonucleotide moiety comprises a sequence that is complementary to the RNA component of human telomerase. The compounds inhibit telomerase activity in cells with a high potency and have superior cellular uptake characteristics.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 9, 2004 and granted December 10, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 9, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 9, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.